| Schedule of Consolidated VIE and Subsidiaries of the VIE |
As
of December 31, 2025, the details of the Company’s major subsidiaries, consolidated VIE and the subsidiaries of the VIE are
as follows:
| | | Date of | | Place of | | Percentage of ownership by the Company | | | | Entity | | incorporation | | incorporation | | Direct | | Indirect | | Principal activities | | Subsidiaries: | | | | | | | | | | | | Pom (HK) | | March 12, 2021 | | Hong Kong | | 100% owned by the Company | | — | | Investment holding | | Guangzhou WFOE | | April 6, 2021 | | PRC | | 100% owned by Pom (HK) | | — | | WFOE, Investment holding | | | | | | | | | | | | | | VIE: | | | | | | | | | | | | Qilekang Digital Health | | January 12, 2010 | | PRC | | — | | 94.86% | | Online hospital service and pharmaceutical supply chain | | | | | | | | | | | | | | VIE’s subsidiaries: | | | | | | | | | | | | Guangzhou Qilekang Modern Pharmaceutical Logistics Co., Ltd. (“Modern Logistics”) | | October 24, 2002 | | PRC | | — | | 100% owned by Qilekang Digital Health | | Drugs wholesale | | Hangzhou Qilekang Pharmaceutical Co., Ltd. (“Hangzhou Qilekang”) | | July 27, 2016 | | PRC | | — | | 100% owned by Qilekang Digital Health | | Offline retail pharmacy and drugs wholesale | | Nanjing Qilekang Pharmaceutical Co., Ltd. (“Nanjing Qilekang”) | | November 13, 2018 | | PRC | | — | | 80% owned by Qilekang Digital Health | | Drugs sales | | Suzhou Qilekang Pharmaceutical Co., Ltd. (“Suzhou Qilekang”) | | September 2, 2024 | | PRC | | — | | 100% owned by Qilekang Digital Health | | Drugs sales | | Guangzhou Qilekang Cloud Technology Co., Ltd. (“Guangzhou Cloud Tech”) | | November 5, 2024 | | PRC | | — | | 100% owned by Qilekang Digital Health | | Online service and pharmaceutical supply chain | | Guangzhou Pomegranate Cloud Pharma Health Industry Technology Co., Ltd. | | February 20, 2025 | | PRC | | — | | 100% owned by Qilekang Cloud Technology | | Drugs sales | | Guangzhou Wanggang International Medical Management Co., Ltd. | | September 26, 2017 | | PRC | | — | | 100% owned by Qilekang Cloud Technology | | Drugs sales |
|
| Schedule of Financial Information for the VIE |
The
following tables represent the selected financial information for the VIE as of December 31, 2024 and 2025 and for the years
ended December 31, 2023, 2024 and 2025.
| | |
December 31,
2024 | | |
December 31,
2025 | | |
December 31,
2025 | |
| | |
RMB | | |
RMB | | |
US$ | |
| Current
assets | |
| 37,880,384 | | |
| 46,138,392 | | |
| 6,597,704 | |
| Non-current
assets | |
| 8,730,173 | | |
| 2,590,800 | | |
| 370,480 | |
| Total
assets | |
| 46,610,557 | | |
| 48,729,192 | | |
| 6,968,184 | |
| Current
liabilities | |
| 179,145,271 | | |
| 264,182,042 | | |
| 37,777,533 | |
| Non-current
liabilities | |
| 366,763,077 | | |
| 370,685,951 | | |
| 53,007,385 | |
| Total
liabilities | |
| 545,908,348 | | |
| 634,867,993 | | |
| 90,784,918 | |
| Net
deficit | |
| (499,297,791 | ) | |
| (586,138,801 | ) | |
| (83,816,734 | ) |
| | |
For
the Years Ended December 31, | |
| | |
2023 | | |
2024 | | |
2025 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | |
| Net
revenues | |
| 304,852,971 | | |
| 342,557,920 | | |
| 399,914,964 | | |
| 57,187,079 | |
| Net
loss | |
| (36,949,421 | ) | |
| (37,365,434 | ) | |
| (130,931,921 | ) | |
| (18,723,015 | ) |
| | |
For the Years Ended December 31, | |
| | |
2023 | | |
2024 | | |
2025 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | |
| Net cash used in operating activities | |
| (45,831,182 | ) | |
| (16,155,582 | ) | |
| (11,414,010 | ) | |
| (1,632,182 | ) |
| Net cash used in investing activities | |
| (111,891 | ) | |
| (33,373 | ) | |
| (1,607,753 | ) | |
| (229,906 | ) |
| Net cash provided by financing activities | |
| 50,067,178 | | |
| 17,016,080 | | |
| 13,870,644 | | |
| 1,983,476 | |
|